| meta-analysis | Q815382 |
| scholarly article | Q13442814 |
| P50 | author | Nicholas J. Shaheen | Q64749672 |
| P2093 | author name string | Amitabh Chak | |
| John M Inadomi | |||
| Siddharth Singh | |||
| Prasad G Iyer | |||
| Sachin Wani | |||
| Apoorva Krishna Chandar | |||
| Don Chamil Codipilly | |||
| P2860 | cites work | Recent developments in pathogenesis, diagnosis and therapy of Barrett's esophagus | Q26864783 |
| The Cochrane Collaboration's tool for assessing risk of bias in randomised trials | Q27860509 | ||
| The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration | Q28131636 | ||
| Impact of endoscopic surveillance on mortality from Barrett's esophagus-associated esophageal adenocarcinomas | Q30544316 | ||
| Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study | Q34084558 | ||
| American Gastroenterological Association medical position statement on the management of Barrett's esophagus | Q34168686 | ||
| Incidence of adenocarcinoma among patients with Barrett's esophagus | Q34223900 | ||
| Ten criteria for effective screening: their application to multislice CT screening for pulmonary and colorectal cancers | Q34261629 | ||
| Oesophageal carcinoma | Q34325751 | ||
| British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus | Q34380645 | ||
| Long-term survival after esophagectomy for Barrett's adenocarcinoma in endoscopically surveyed and nonsurveyed patients | Q34621799 | ||
| Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma | Q35351828 | ||
| Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans | Q36348413 | ||
| Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study | Q36783294 | ||
| Trends in esophageal adenocarcinoma incidence and mortality. | Q37096847 | ||
| Barrett's surveillance identifies patients with early esophageal adenocarcinoma | Q37732727 | ||
| The risk of oesophageal adenocarcinoma in a prospectively recruited Barrett's oesophagus cohort | Q37744623 | ||
| Effect of Barrett's esophagus surveillance on esophageal preservation, tumor stage, and survival with esophageal adenocarcinoma | Q38073456 | ||
| The Impact of a Prior Diagnosis of Barrett's Esophagus on Esophageal Adenocarcinoma Survival. | Q38856701 | ||
| The evolution and outcome of surveillance of Barrett's oesophagus over four decades in a UK District General Hospital | Q39443885 | ||
| ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus | Q40365358 | ||
| Pathogenesis and progression of oesophageal adenocarcinoma varies by prior diagnosis of Barrett's oesophagus. | Q40516702 | ||
| Understanding and Avoiding Immortal-Time Bias in Gastrointestinal Observational Research | Q40590489 | ||
| Surveillance endoscopy is associated with improved outcomes of oesophageal adenocarcinoma detected in patients with Barrett's oesophagus | Q40603074 | ||
| Impact of surveillance for Barrett's oesophagus on tumour stage and survival of patients with neoplastic progression | Q41027075 | ||
| Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial | Q41231837 | ||
| Natural History of Early Esophageal Squamous Carcinoma and Early Adenocarcinoma of the Gastric Cardia in the People's Republic of China | Q43825736 | ||
| Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes | Q45040932 | ||
| Surveillance of Barrett's esophagus and mortality from esophageal adenocarcinoma: a population-based cohort study | Q45740170 | ||
| Surveillance and survival in Barrett's adenocarcinomas: a population-based study | Q46131128 | ||
| The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends | Q47322343 | ||
| Oesophageal adenocarcinoma and prior diagnosis of Barrett's oesophagus: a population-based study | Q48874889 | ||
| Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. | Q50875389 | ||
| Long-term survival and cost analysis of an annual Barrett's surveillance programme. | Q51138124 | ||
| Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer. | Q52858914 | ||
| Outcome of esophageal adenocarcinoma detected during endoscopic biopsy surveillance for Barrett's esophagus | Q57546300 | ||
| Risk factors for the development of an adenocarcinoma in columnar-lined (Barrett) esophagus. The Rotterdam Esophageal Tumor Study Group | Q72851707 | ||
| Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia | Q74455533 | ||
| Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus | Q74564550 | ||
| Barrett's surveillance is worthwhile and detects curable cancers. A prospective cohort study addressing cancer incidence, treatment outcome and survival | Q81043907 | ||
| The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence | Q81290009 | ||
| Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends | Q83982909 | ||
| Endoscopic therapy for Barrett's oesophagus | Q86874494 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Barrett's esophagus | Q808892 |
| P577 | publication date | 2018-02-16 | |
| P1433 | published in | Gastroenterology | Q4039279 |
| P1476 | title | The Effect of Endoscopic Surveillance in Patients with Barrett's Esophagus: A Systematic Review and Meta-analysis |
| Q95488201 | Barrett oesophagus |
| Q57049158 | Does Sleeve Gastrectomy Cause Barrett's Oesophagus? |
| Q61451290 | Endoscopic surveillance or ablation for Barrett's esophagus? |
| Q91868255 | Is Mass Screening for Barrett's Esophagus a Myth or Reality? |
| Q64079648 | Screening for Barrett's Esophagus: Balancing Clinical Value and Cost-effectiveness |
| Q98386967 | Update on endoscopic treatment of Barrett's oesophagus and Barrett's oesophagus-related neoplasia |
Search more.